PDCD1 and neoplasm: Escape from tumor immunity after PD-1 blockade can occur due to (1) inherent low immunogenicity of the tumor, (2) impaired T-cell trafficking and retention of T cells in the tumor, or (3) inhibitory factors expressed in the tumor microenvironment that prevent T-cell activation.